We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+11.39%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$7.66B
AUM Growth
+$952M
Cap. Flow
+$371M
Cap. Flow %
4.84%
Top 10 Hldgs %
9.93%
Holding
1,511
New
90
Increased
296
Reduced
294
Closed
110

Top Sells

Rank Stock Value
1
TSN icon
Tyson Foods
TSN
+$63.7M
2
JPM icon
JPMorgan Chase
JPM
+$46.6M
3
ATVI
Activision Blizzard
ATVI
+$40.5M
4
AWK icon
American Water Works
AWK
+$37.3M
5
SYY icon
Sysco
SYY
+$36.7M

Sector Composition

Rank Sector Weight
1 Financials 23.67%
2 Industrials 15.1%
3 Technology 11.49%
4 Consumer Discretionary 9.68%
5 Healthcare 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYUT
1151
DELISTED
Synutra International, Inc.
SYUT
$406K 0.01%
75,900
+50,000
+193% +$241K
AORT icon
1152
Artivion
AORT
$1.3B
$404K 0.01%
21,120
-75,000
-78% -$1.37M
ALJJ
1153
DELISTED
ALJ Regional Holdings Inc
ALJJ
$403K 0.01%
91,700
+70,000
+323% +$300K
REIS
1154
DELISTED
Reis, Inc.
REIS
$403K 0.01%
18,100
IEC
1155
DELISTED
IEC Electronics Corp.
IEC
$402K 0.01%
112,550
SANW
1156
DELISTED
S&W Seed Co
SANW
$401K 0.01%
4,584
KBAL
1157
DELISTED
Kimball International
KBAL
$400K 0.01%
22,774
-23,626
-51% -$347K
LAYN
1158
DELISTED
Layne Christensen Co
LAYN
$399K 0.01%
36,680
+250
+0.7% +$2.42K
DXYN
1159
DELISTED
Dixie Group Inc
DXYN
$398K 0.01%
110,600
INFI
1160
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$397K 0.01%
293,800
GLBR
1161
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
$395K 0.01%
56,000
HNNA icon
1162
Hennessy Advisors
HNNA
$77.7M
$394K 0.01%
18,600
-75
-0.4% -$1.59K
UPLD icon
1163
Upland Software
UPLD
$12.8M
$394K 0.01%
4,400
+1,000
+29% +$88K
MFNC
1164
DELISTED
Mackinac Financial Corporation
MFNC
$393K 0.01%
29,200
IMUX icon
1165
Immunic
IMUX
$190M
$392K 0.01%
225
NMRX
1166
DELISTED
Numerex Corp
NMRX
$392K 0.01%
52,908
HHS icon
1167
Harte-Hanks
HHS
$16.2M
$391K 0.01%
25,890
INTX
1168
DELISTED
Intersections, Inc.
INTX
$390K 0.01%
97,800
ELMD icon
1169
Electromed
ELMD
$337M
$388K 0.01%
100,000
+10,000
+11% +$41.3K
MBII
1170
DELISTED
Marrone Bio Innovations, Inc.
MBII
$388K 0.01%
181,200
NVIV
1171
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$381K 0.01%
5
MEET
1172
DELISTED
The Meet Group, Inc. Common Stock
MEET
$381K 0.01%
77,331
ALCO icon
1173
Alico
ALCO
$280M
$377K ﹤0.01%
13,900
RIGL icon
1174
Rigel Pharmaceuticals
RIGL
$681M
$376K ﹤0.01%
15,780
-4,000
-20% -$115K
CORT icon
1175
Corcept Therapeutics
CORT
$12.4B
$375K ﹤0.01%
+51,700
New +$405K

Similar funds

Bridgeway Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Bridgeway Capital Management held 1,511 positions worth $7.66B, up 14% from $6.71B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Bridgeway Capital Management deployed $371M of net new capital in Q4 2016, opening 90 new positions and adding to 296 existing holdings. Its largest new stake was LyondellBasell Industries: 655,800 shares worth $56.3M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Tyson Foods, an estimated $63.7M trimmed.

  • Bridgeway Capital Management's largest Q4 2016 buy was LyondellBasell Industries: 655,800 shares worth $56.3M.
  • Bridgeway Capital Management added most to Bank of America in Q4 2016, an estimated $62.8M increase.
  • Bridgeway Capital Management's biggest Q4 2016 reduction was Tyson Foods, cutting an estimated $63.7M.
  • Bridgeway Capital Management fully exited Activision Blizzard in Q4 2016, selling an estimated $40.5M.
  • Bridgeway Capital Management's ten largest holdings make up 9.9% of its $7.66B portfolio in Q4 2016.
  • Bridgeway Capital Management opened 90 new positions and closed 110 in Q4 2016.
  • Bridgeway Capital Management's portfolio value rose 14% quarter-over-quarter to $7.66B.

Based on Bridgeway Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.